Advertisement

Benign Bone Tumors

  • Robert SteffnerEmail author
Chapter
Part of the Cancer Treatment and Research book series (CTAR, volume 162)

Abstract

Benign bone lesions are a broad category that demonstrates a spectrum of activities from latent to aggressive. Differentiating the various tumors is important in order to properly determine necessary intervention. This chapter focuses on the presentation, imaging, diagnostic features, and treatment of the most common benign bone tumors in order to help guide diagnosis and management.

Keywords

Incidental Latent Observation Aggressive Curettage Adjuvant 

References

  1. 1.
    Ardran GM (1951) Bone destruction not demonstrable by radiography. Br J Radiol 278(24):107–109Google Scholar
  2. 2.
    Costelloe CM, Madewell JE (2013) Radiography in the initial diagnosis of primary bone tumors. AJR 200:3–7PubMedGoogle Scholar
  3. 3.
    Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 204:9–24PubMedGoogle Scholar
  4. 4.
    Shapeero LG, Vanel D (2000) Imaging evaluation of the response of high-grade osteosarcoma and ewing sarcoma to chemotherapy with emphasis on dynamic contrast-enhanced magnetic resonance imaging. Semin Musculoskelet Radiol 4(1):137–146PubMedGoogle Scholar
  5. 5.
    Hwang S, Panicek DM (2009) The evolution of musculoskeletal tumor imaging. Radiol Clin North Am 47(3):435–453PubMedGoogle Scholar
  6. 6.
    Dyke JP, Panicek DM, Healey JH et al (2003) Osteogenic and ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast enhanced MR imaging. Radiology 228(1):271–278PubMedGoogle Scholar
  7. 7.
    Karchevsky M, Babb JS, Schweitzer ME (2008) Can diffusion-weighted imaging be used to differentiate benign from pathologic fractures? A meta-analysis. Skeletal Radiol 37(9):791–795PubMedGoogle Scholar
  8. 8.
    Girish G, Finlay K, Morag Y, et al (2012) Imaging review of skeletal tumors of the pelvis—part I: benign tumors of the pelvis. Sci World J. Epub May 15 PMID: 22666102Google Scholar
  9. 9.
    Roberts CC, Daffner RH, Weissman BN et al (2006) ACR appropriateness criteria on metastatic bond disease. J Am Coll Radiol 7(6):400–409Google Scholar
  10. 10.
    Aoki J, Watanabe H, Shinozaki T et al (2001) FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 219(3):774–777PubMedGoogle Scholar
  11. 11.
    Buchbender C, Heusner TA, Lauenstein TC et al (2012) Oncologic PET/MRI, part 2: bone Tumors, soft-tissue tumors, melanoma, and lymphoma. J Nucl Med 53:1244–1252PubMedGoogle Scholar
  12. 12.
    Betsy M, Kupersmith LM, Springfield DS (2004) Metaphyseal fibrous defects. J Am Acad Orthop Surg 12(2):89–95PubMedGoogle Scholar
  13. 13.
    Motamedi K, Seeger LL (2011) Benign bone tumors. Radiol Clin N Am 49:1115–1134PubMedGoogle Scholar
  14. 14.
    Cronin MV, Hughes TH (2012) Bone tumors and tumor-like conditions of bone. Appl Radiol 41(10):6–15Google Scholar
  15. 15.
    Mankin HJ, Trahan CA, Fondren G et al (2009) Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review. Musculoskelet Surg 93:1–7Google Scholar
  16. 16.
    Jee WH, Choe BY, Kang HS et al (1998) Non-ossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology 209(1):197–202PubMedGoogle Scholar
  17. 17.
    Fitzpatrick KA, Taljanovic MS, Speer DP et al (2004) Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. AJR 182(6):1389–1398PubMedGoogle Scholar
  18. 18.
    Brant WE, Helms CA (2007) Fundamentals of diagnostic radiology, 3rd edn. LWW, PhiladelphiaGoogle Scholar
  19. 19.
    Manaster BJ, Disler DG, May DA et al (2002) Musculoskeletal imaging: the requisites, 2nd edn. Mosby, St LouisGoogle Scholar
  20. 20.
    Gleason BC, Liegl-Atzwanger B, Kozakewich HP et al (2008) Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisal. Am J Surg Pathol 32(3):363–376PubMedGoogle Scholar
  21. 21.
    Ishida T, Iijima T, Kikuchi F et al (1992) A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol 21(8):493–502PubMedGoogle Scholar
  22. 22.
    Most MJ, Sims FH, Inwards CY (2010) Osteofibrous dysplasia and adamantinoma. J Am Acad Orthop Surg 18:358–366PubMedGoogle Scholar
  23. 23.
    Dorfman HC, Czerniak B (1988) Bone tumors, 1st edn. CV Mosby, St LouisGoogle Scholar
  24. 24.
    Murphey MD, Flemming DJ, Boyea SR et al (1998) Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating features. Radiographics 18(5):1213–1237PubMedGoogle Scholar
  25. 25.
    Simon MA, Peabody TD, Haydon RC, et al (2009) Musculoskeletal clinicopathologic course. In: Lecture notes, University of Chicago, Chicago, 26–28 October 2009Google Scholar
  26. 26.
    Jaffe HL (1943) Hereditary multiple exostosis. Arch Pathol 36:335–357Google Scholar
  27. 27.
    Thakur NA, Daniels AH, Schiller J et al (2012) Benign tumors of the spine. J Am Acad Orthop Surg 20:715–724PubMedGoogle Scholar
  28. 28.
    Brien EW, Mirra JM, Luck JV (1999) Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. II: juxtacortical cartilage tumors. Skeletal Radiol 28(1):1–20PubMedGoogle Scholar
  29. 29.
    Edeiken J (1990) Roentgen diagnosis of diseases of bone, 3rd edn. Williams and Wilkins, BaltimoreGoogle Scholar
  30. 30.
    Pedrini E, DeLuca A, Valente EM et al (2005) Novel EXT1 and EXT2 mutations identified by DHPLC in Italian patients with multiple osteochondromas. Hum Mutat 26(3):280PubMedGoogle Scholar
  31. 31.
    American Academy of Orthopaedic Surgeons (AAOS) (2012) Chondromyxoid fibroma. OrthoInfo. http://orthoinfo.aaos.org/topic.cfm?topic=A00624
  32. 32.
    Rosenthal D, Callstrom MR (2012) Critical review and state of the art in interventional oncology: Benign and metastatic disease involving bone. Radiology 262(3):765–780PubMedGoogle Scholar
  33. 33.
    Petsas T, Megas P, Papathanassiou Z (2007) Radio-frequency ablation of two femoral head chondroblastomas. Eur J Radiol 63(1):63–67PubMedGoogle Scholar
  34. 34.
    Greenspan A (1993) Benign bone-forming lesions: osteoma, osteoid osteoma, and osteoblastoma. Clinical, imaging, pathologic, and differential considerations. Skeletal Radiol 22(7):485–500PubMedGoogle Scholar
  35. 35.
    Eggel Y, Theumann N, Lüthi F (2007) Intra-articular osteoid osteoma of the knee: clinical and therapeutical particularities. Joint Bone Spine 74(4):379–381PubMedGoogle Scholar
  36. 36.
    Jackson RP, Reckling FW, Mants FA (1977) Osteoid osteoma and osteoblastoma: similar histologic lesions with different natural histories. Clin Orthop Relat Res 128:303–313PubMedGoogle Scholar
  37. 37.
    Cerase A, Priolo F (1998) Skeletal benign bone-forming lesions. Eur J Radiol 27(suppl 1):S91–S97PubMedGoogle Scholar
  38. 38.
    Peyser A, Applbaum Y, Simanovsky N et al (2009) CT-guided radiofrequency ablation of pediatric osteoid osteoma utilizing a water-cooled tip. Ann Surg Oncol 16(10):2856–2861PubMedGoogle Scholar
  39. 39.
    Kiers L, Shield LK, Cole WG (1990) Neurological manifestations of osteoid osteoma. Arch Dis Child 65(8):851–855PubMedCentralPubMedGoogle Scholar
  40. 40.
    Lindner NJ, Ozaki T, Roedl R et al (2001) Percutaneous radiofrequency ablation in osteoid osteoma. J Bone Joint Surg Br 83(3):391–396PubMedGoogle Scholar
  41. 41.
    Davies M, Cassar-Pullicino VN, Davies AM et al (2002) The diagnostic accuracy of MR imaging in osteoid osteoma. Skeletal Radiol 31(10):559–569PubMedGoogle Scholar
  42. 42.
    Schulman L, Dorfman HD (1970) Nerve fibers in osteoid osteoma. J Bone Joint Surg Am 52(7):1351–1356PubMedGoogle Scholar
  43. 43.
    Mankin HJ (2009) Osteoid osteoma and osteoblastoma: two related bone tumors, in great educator series: pathophysiology of orthopaedic diseases, vol 2. American Academy of Orthopaedic Surgeons, Rosemont, pp 79–85Google Scholar
  44. 44.
    Makley JT, Dunn MJ (1982) Prostaglandin synthesis by osteoid osteoma. Lancet 2(8288):42PubMedGoogle Scholar
  45. 45.
    Greco F, Tamburrelli F, Ciabattoni G (1991) Prostaglandins in osteoid osteoma. Int Orthop 15(1):35–37PubMedGoogle Scholar
  46. 46.
    Kneisl JS, Simon MA (1992) Medical management compared with operative treatment for osteoid osteoma. J Bone Joint Surg Am 74(2):179–185PubMedGoogle Scholar
  47. 47.
    Roqueplan F, Porcher R, Hamzé B et al (2010) Long-term results of percutaneous resection and interstitial laser ablation of osteoid osteomas. Eur Radiol 20(1):209–217PubMedGoogle Scholar
  48. 48.
    Vanderschueren GM, Obermann WR, Dijkstra SP et al (2009) Radiofrequency ablation of spinal osteoid osteoma: clinical outcome. Spine 34(9):901–904PubMedGoogle Scholar
  49. 49.
    Rosenthal DI, Hornicek FJ, Torriani M et al (2003) Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 229(1):171–175PubMedGoogle Scholar
  50. 50.
    Rosenthal DI, Hornicek FJ, Wolfe MW, Jennings LC, Gebhardt MC, Mankin HJ (1999) Decreasing length of hospital stay in treatment of osteoid osteoma. Clin Orthop Relat Res 361:186–191PubMedGoogle Scholar
  51. 51.
    Rimondi E, Mavrogenis AF, Rossi G et al (2012) Radiofrequency ablation for non-spinal osteoid osteomas in 557 patients. Eur Radiol 22(1):181–188PubMedGoogle Scholar
  52. 52.
    Berry M, Mankin H, Gebhardt M, Rosenberg A, Hornicek F (2008) Osteoblastoma: A 30-year study of 99 cases. J Surg Oncol 98(3):179–183PubMedGoogle Scholar
  53. 53.
    Lucas DR, Unni KK, McLeod RA et al (1994) Osteoblastoma: clinicopathologic study of 306 cases. Hum Pathol 25(2):117–134PubMedGoogle Scholar
  54. 54.
    Frassica FJ, Waltrip RL, Sponseller PD et al (1996) Clinicopathologic features and treatment of osteoid osteoma and osteoblastoma in children and adolescents. Orthop Clin North Am 27(3):559–574PubMedGoogle Scholar
  55. 55.
    Arkader A, Dormans JP (2008) Osteoblastoma in the skeletally immature. J Pediatr Orthop 28(5):555–560PubMedGoogle Scholar
  56. 56.
    Motamedi K, IIaslan H, Seeger LL (2004) Imaging of the lumbar spine neoplasms. Semin Ultrasound CT MR 25:474–489PubMedGoogle Scholar
  57. 57.
    Crim JR, Mirra JM, Eckardt JJ et al (1990) Widespread inflammatory response to osteoblastoma; the flare phenomenon. Radiology 177(3):835–836PubMedGoogle Scholar
  58. 58.
    American Academy of Orthopaedic Surgeons (AAOS) (2013) Unicameral bone cyst. OrthoInfo. http://orthoinfo.aaos.org/topic.cfm?topic=A00081
  59. 59.
    Azevedo CP, Casanova JM, Guerra MG et al (2013) Tumors of the foot and ankle: a single-institution experience. J Foot Ankle Surg 52:147–152PubMedGoogle Scholar
  60. 60.
    Guo W, Xu W, Huvos AG et al (1999) Comparative frequency of bone sarcomas among different racial groups. Chin Med J (Engl) 112:1101–1104Google Scholar
  61. 61.
    Sung HW, Kuo DP, Shu WP et al (1982) Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am 64:755–761PubMedGoogle Scholar
  62. 62.
    Rendina D, Mossetti G, Soscia E et al (2004) Giant cell tumor and Paget’s disease of bone in one family: geographic clustering. Clin Orthop Relat Res 421:218–224PubMedGoogle Scholar
  63. 63.
    Jacobs TP, Michelsen J, Polay JS et al (1979) Giant cell tumor in Paget’s disease of bone: familial and geographic clustering. Cancer 44:742–747PubMedGoogle Scholar
  64. 64.
    Campanacci M, Baldini N, Boriani S, Sudanese A (1987) Giant-cell tumor of bone. J Bone Joint Surg Am 69:106–114PubMedGoogle Scholar
  65. 65.
    Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120PubMedGoogle Scholar
  66. 66.
    Murphey MD, Nomikos DJ, Flemming FH et al (2001) From the archives of the AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologie-pathologic correlation. Radiographics 21(5):1283–1309PubMedGoogle Scholar
  67. 67.
    Parman LM, Murphey MD (2000) Alphabet soup: cystic lesions of bone. Semin Musculoskelet Radiol 4(1):89–101PubMedGoogle Scholar
  68. 68.
    Skubitz KM, Cheng EY, Clohisy DR et al (2004) Gene expression in giant-cell tumors. J Lab Clin Med 144:193–200PubMedGoogle Scholar
  69. 69.
    Morgan T, Atkins GJ, Trivett MK et al (2005) Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol 167:117–128PubMedCentralPubMedGoogle Scholar
  70. 70.
    WHO (2002) Pathology and genetics of tumours of soft tissue and bone. IARC Press, LyonGoogle Scholar
  71. 71.
    Klenke FM, Wenger DE, Inwards CY et al (2011) Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res 469(2):591–599PubMedCentralPubMedGoogle Scholar
  72. 72.
    Ng ES, Saw A, Sengupta S, et al (2002) Giant cell tumour of bone with late presentation: review of treatment and outcome. J Orthop Surg (Hong Kong) 10:120–28Google Scholar
  73. 73.
    Makis W, Alabed YZ, Nahal A et al (2012) Giant cell tumor pulmonary metastases mimic primary malignant pulmonary nodules on 18F-FDG PET/CT. Nucl Med Mol Imaging 46:134–137PubMedCentralPubMedGoogle Scholar
  74. 74.
    Thomas D, Henshaw R, Skubitz K et al (2010) Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 11(3):275–280PubMedGoogle Scholar
  75. 75.
    Smith MR, Saad F, Coleman R et al (2012) Denosumab and bone-metastasis-free and survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet 379:39–46PubMedCentralPubMedGoogle Scholar
  76. 76.
    Zwolak P, Manivel JC, Jasinski P et al (2010) Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines. J Bone Joint Surg Am 92(1):162–168PubMedGoogle Scholar
  77. 77.
    Klenke FM, Wenger DE, Inwards CY et al (2011) Recurrent giant cell tumor of long bones: analysis of surgical management. Clin Orthop Relat Res 469(4):1181–1187PubMedCentralPubMedGoogle Scholar
  78. 78.
    Ye Y, Pringle LM, Lau AW et al (2010) TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene 29(25):3619–3629PubMedCentralPubMedGoogle Scholar
  79. 79.
    Kransdorf MJ, Sweet DE (1995) Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR 164(3):573–580PubMedGoogle Scholar
  80. 80.
    Schajowicz F (1993) Histological typing of bone tumors (international histological classification of tumors). Springer, New YorkGoogle Scholar
  81. 81.
    Garg S, Mehta S, Dormans JP (2004) Langerhans cell histiocytosis of the spine in children: long-term follow-up. J Bone Joint Surg Am 86(8):1740–1750PubMedGoogle Scholar
  82. 82.
    Yeom JS, Lee CK, Shin HY, Lee CS, Han CS, Chang H (1999) Langerhans’ cell histiocytosis of the spine: Analysis of twenty-three cases. Spine 24(16):1740–1749PubMedGoogle Scholar
  83. 83.
    Huang W, Yang X, Cao D et al (2010) Eosinophilic granuloma of spine in adults: a report of 30 cases and outcome. Acta Neurochir 152(7):1129–1137PubMedGoogle Scholar
  84. 84.
    Cerase A, Priolo F (1998) Skeletal benign bone forming lesions. Eur J Radiol 27:91–97Google Scholar
  85. 85.
    Campbell RS, Grainger AJ, Mangham DC et al (2003) Intraosseous lipoma: report of 35 new cases and a review of the literature. Skeletal Radiol 32:209–222PubMedGoogle Scholar
  86. 86.
    Hermann G, Singson R, Bromley M et al (2004) Cystic degeneration of medullary bone infarction evaluated with magnetic resonance imaging correlated with pathologic examination. Can Assoc Radiol J 55(5):321–325PubMedGoogle Scholar
  87. 87.
    Baudrez V, Galant C, Van de Berg BC (2001) Benign vertebral hemangiomas: MR-histological correlation. Skeletal Radiol 30:442–446PubMedGoogle Scholar
  88. 88.
    Baek HJ, Lee SJ, Cho KH et al (2010) Subungual tumors: clinicopathologic correlation with US and MR imaging findings. Radiographics 30:1621–1636PubMedGoogle Scholar
  89. 89.
    Steffner RJ, Liao C, Stacy G et al (2011) Factors associated with recurrence of primary aneurysmal bone cysts: is argon beam coagulation an effective adjuvant treatment? J Bone Joint Surg Am 93(21):e1221–e1229PubMedGoogle Scholar
  90. 90.
    Campanacci M, Baldini N, Boriani S, Sudanese A (1987) Giant-cell tumor of bone. J Bone Joint Surg Am 69(1):106–114PubMedGoogle Scholar
  91. 91.
    Becker WT, Dohle J et al (2008) Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am 90(5):1060–1067PubMedGoogle Scholar
  92. 92.
    Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS (1999) Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am 81(6):811–820PubMedGoogle Scholar
  93. 93.
    Turcotte RE, Wunder JS, Isler MH et al (2002) Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res 397:248–258PubMedGoogle Scholar
  94. 94.
    Malawer MM, Bickels J, Meller I et al (1999) Cryosurgery in the treatment of giant cell tumor. A long-term followup study. Clin Orthop Relat Res 359:176–188PubMedGoogle Scholar
  95. 95.
    Dürr HR, Maier M, Jansson V, Baur A, Refior HJ (1999) Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone. Eur J Surg Oncol 25(6):610–618PubMedGoogle Scholar
  96. 96.
    Gibbs CP, Hefele MC, Peabody TD et al (1999) Aneurysmal bone cyst of the extremities. Factors related to local recurrence after curettage with a high-speed burr. J Bone Joint Surg Am 81(12):1671–1678PubMedGoogle Scholar
  97. 97.
    O’Donnell RJ, Springfield DS, Motwani HK et al (1994) Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am 76(12):1827–1833PubMedGoogle Scholar
  98. 98.
    Lewis VO, Wei A, Mendoza T et al (2007) Argon beam coagulation as an adjuvant for local control of giant cell tumor. Clin Orthop Relat Res 454:192–197PubMedGoogle Scholar
  99. 99.
    Marcove RC, Sheth DS, Takemoto S et al (1995) The treatment of aneurysmal bone cyst. Clin Orthop Relat Res 311:157–163PubMedGoogle Scholar
  100. 100.
    Schreuder HW, Veth RP (1997) Simple bone cysts treated by injection of autologous bone marrow. J Bone Joint Surg Br 79(5):877PubMedGoogle Scholar
  101. 101.
    Marcove RC (1982) A 17-year review of cryosurgery in the treatment of bone tumors. Clin Orthop Relat Res 163:231–234PubMedGoogle Scholar
  102. 102.
    Malawer MM, Marks MR, McChesney D et al (1988) The effect of cryosurgery and polymethylmethacrylate in dogs with experimental bone defects comparable to tumor defects. Clin Orthop Relat Res 226:299–310PubMedGoogle Scholar
  103. 103.
    Quint U, Vanhöfer U, Harstrick A et al (1996) Cytotoxicity of phenol to musculoskeletal tumours. J Bone Joint Surg Br 78(6):984–985PubMedGoogle Scholar
  104. 104.
    Lack W, Lang S, Brand G (1994) Necrotizing effect of phenol on normal tissues and on tumors. A study on postoperative and cadaver specimens. Acta Orthop Scand 65(3):351–354PubMedGoogle Scholar
  105. 105.
    Quint U, Müller RT, Müller G (1998) Characteristics of phenol. Instillation in intralesional tumor excision of chondroblastoma, osteoblastoma and enchondroma. Arch Orthop Trauma Surg 117(1–2):43–46PubMedGoogle Scholar
  106. 106.
    Rock M (1990) Adjuvant management of benign tumors; basic concepts of phenol and cement use. Chir Organi Mov 75(1 suppl):195–197PubMedGoogle Scholar
  107. 107.
    Bristow RE, Smith Sehdev AE, Kaufman HS, et al (2001) Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction. Gynecol Oncol 83(1):49–55Google Scholar
  108. 108.
    Heck RK, Pope WE, Ahn JI et al (2009) Histologic evaluation of the depth of necrosis produced by argon beam coagulation: implications for use as adjuvant treatment of bone tumors. J Surg Orthop Adv 18(2):69–73PubMedGoogle Scholar
  109. 109.
    Ozaki T, Hillmann A, Lindner N et al (1996) Aneurysmal bone cysts in children. J Cancer Res Clin Oncol 122(12):767–769PubMedGoogle Scholar
  110. 110.
    Fillingham YA, Lenart BA, Gitelis S (2012) Function after injection of benign bone lesions with a bioceramic. Clin Orthop Relat Res 470(7):2014–2020PubMedCentralPubMedGoogle Scholar
  111. 111.
    Evaniew N, Tan V, Parasu N et al (2013) Use of a calcium sulfate-calcium phosphate synthetic bone graft composite in the surgical management of primary bone tumors. Orthopedics 36(2):e216–e222PubMedGoogle Scholar
  112. 112.
    Peyser A, Applbaum Y (2009) Radiofrequency ablation of bone tumors. Curr Orthop Pract 20(6):616–621Google Scholar
  113. 113.
    Rastogi S, Varshney MK, Trikha V et al (2006) Treatment of aneurysmal bone cysts with percutaneous sclerotherapy using polidocanol. A review of 72 cases with long-term follow-up. J Bone Joint Surg Br 88(9):1212–1216PubMedGoogle Scholar
  114. 114.
    Varshney MK, Rastogi S, Khan SA et al (2010) Is sclerotherapy better than intralesional excision for treating aneurysmal bone cysts? Clin Orthop Relat Res 468(6):1649–1659PubMedCentralPubMedGoogle Scholar
  115. 115.
    Feigenberg SJ, Marcus RB Jr, Zlotecki RA et al (2003) Radiation therapy for giant cell tumors of bone. Clin Orthop Relat Res 411:207–216PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.Orthopaedic OncologyUC Davis Comprehensive Cancer CenterSacramentoUSA

Personalised recommendations